Blog
Efficacy and Safety of Ruxolitinib Cream Among Children With Atopic Dermatitis Aged 2 to 6 Years and 7 to <12 Years: Results from a Phase 3 Double-Blind Vehicle-Controlled Study
Ruxolitinib cream was efficient and properly tolerated to eight weeks in a section 3 ...
Resident memory T cells in nonlesional skin and healed lesions of patients with chronic inflammatory diseases: Appearances can be deceptive
Tissue-resident reminiscence T (TRM) cells function a primary line of protection in ...
Lower socioeconomic status may help explain racial disparities in asthma and atopic dermatitis prevalence: A mediation analysis
Racial disparities in atopic illness (atopic dermatitis , bronchial asthma, and allergy ...
Neutrophil extracellular traps promote ΔNp63+ basal cell hyperplasia in chronic rhinosinusitis
Continual rhinosinusitis (CRS) is a heterogeneous continual irritation of the paranasal ...
Cholinergic sensing of allergen exposure by airway epithelium promotes type 2 immunity in the lungs
The incidence of allergic illnesses and bronchial asthma has elevated over the previous ...
Asthma morbidity measures across Black ethnic subgroups
Bronchial asthma is a standard persistent respiratory illness that impacts roughly 8.0% ...
Unveiling the Reasons for Disparities in Prevalence of Asthma and Allergic Conditions in Black Children: The Role of Socioeconomic Status
Unveiling the Causes for Disparities in Prevalence of Bronchial asthma and Allergic ...
Rethinking PID – Why the distinction between primary and secondary immune disorders is relevant more frequently than between inborn and acquired errors of immunity
Rethinking PID - Why the excellence between main and secondary immune problems is related ...
